Ciena Corporation
CIEN · NYSE
Analyst ratings
buy · 14 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| June 23, 2026 | Needham | Reiterates | Buy | $600.00 |
| June 5, 2026 | UBS | Maintains | Neutral | $508.00 |
| June 5, 2026 | Barclays | Maintains | Overweight | $607.00 |
| June 5, 2026 | Morgan Stanley | Maintains | Equal-Weight | $490.00 |
| June 5, 2026 | Rosenblatt | Maintains | Buy | $720.00 |
| June 5, 2026 | Needham | Maintains | Buy | $600.00 |
| June 4, 2026 | Raymond James | Maintains | Outperform | $530.00 |
| June 2, 2026 | B. Riley Securities | Maintains | Neutral | $531.00 |
| May 26, 2026 | B of A Securities | Maintains | Buy | $660.00 |
| May 18, 2026 | Citigroup | Maintains | Buy | $658.00 |
| May 15, 2026 | TD Cowen | Maintains | Buy | $675.00 |
| May 5, 2026 | Stifel | Maintains | Buy | $585.00 |
| April 20, 2026 | Morgan Stanley | Maintains | Equal-Weight | $405.00 |
| April 16, 2026 | JP Morgan | Maintains | Overweight | $550.00 |
| April 16, 2026 | B of A Securities | Maintains | Buy | $550.00 |
| March 23, 2026 | Stifel | Maintains | Buy | $430.00 |
| March 6, 2026 | UBS | Maintains | Neutral | $285.00 |
| March 6, 2026 | Rosenblatt | Maintains | Buy | $350.00 |
| March 6, 2026 | B. Riley Securities | Maintains | Neutral | $283.00 |
| March 6, 2026 | Citigroup | Maintains | Buy | $345.00 |
| March 6, 2026 | Morgan Stanley | Maintains | Equal-Weight | $286.00 |
| March 6, 2026 | Barclays | Maintains | Overweight | $372.00 |
| March 6, 2026 | Stifel | Reiterates | Buy | $320.00 |
| March 6, 2026 | B of A Securities | Upgrades | Buy | $355.00 |
| March 5, 2026 | Needham | Maintains | Buy | $370.00 |
| March 2, 2026 | JP Morgan | Maintains | Overweight | $380.00 |
| February 23, 2026 | Morgan Stanley | Maintains | Equal-Weight | $280.00 |
| February 19, 2026 | Evercore ISI Group | Maintains | In-Line | $330.00 |
| January 22, 2026 | Stifel | Maintains | Buy | $280.00 |
| January 20, 2026 | B of A Securities | Downgrades | Neutral | $260.00 |
| December 17, 2025 | Morgan Stanley | Maintains | Equal-Weight | $213.00 |
| December 12, 2025 | UBS | Maintains | Neutral | $230.00 |
| December 12, 2025 | Citigroup | Maintains | Buy | $280.00 |
| December 12, 2025 | Barclays | Maintains | Overweight | $279.00 |
| December 12, 2025 | JP Morgan | Maintains | Overweight | $250.00 |
| December 12, 2025 | Morgan Stanley | Maintains | Equal-Weight | $195.00 |
| December 12, 2025 | Argus Research | Maintains | Buy | $280.00 |
| December 12, 2025 | Rosenblatt | Maintains | Buy | $305.00 |
| December 12, 2025 | B of A Securities | Maintains | Buy | $260.00 |
| December 11, 2025 | Needham | Maintains | Buy | $280.00 |
| December 9, 2025 | Stifel | Maintains | Buy | $230.00 |
| December 8, 2025 | Needham | Maintains | Buy | $240.00 |
| December 5, 2025 | Needham | Maintains | Buy | $240.00 |
| December 4, 2025 | Rosenblatt | Maintains | Buy | $175.00 |
| December 4, 2025 | Morgan Stanley | Maintains | Equal-Weight | $185.00 |
| November 10, 2025 | Citigroup | Maintains | Buy | $230.00 |
| November 10, 2025 | Evercore ISI Group | Maintains | In-Line | $200.00 |
| October 10, 2025 | Morgan Stanley | Upgrades | Equal-Weight | $140.00 |
| September 26, 2025 | Rosenblatt | Upgrades | Buy | $175.00 |
| September 23, 2025 | Stifel | Maintains | Buy | $152.00 |
| September 17, 2025 | B of A Securities | Maintains | Buy | $155.00 |
| September 5, 2025 | JP Morgan | Maintains | Overweight | $140.00 |
| September 5, 2025 | UBS | Maintains | Neutral | $120.00 |
| September 5, 2025 | Barclays | Maintains | Overweight | $138.00 |
| September 5, 2025 | Argus Research | Maintains | Buy | $135.00 |
| September 5, 2025 | Morgan Stanley | Maintains | Underweight | $100.00 |
| September 5, 2025 | Stifel | Maintains | Buy | $120.00 |
| September 5, 2025 | B. Riley Securities | Downgrades | Neutral | $113.00 |
| September 5, 2025 | B of A Securities | Maintains | Buy | $135.00 |
| September 5, 2025 | Rosenblatt | Maintains | Neutral | $127.50 |
| September 5, 2025 | Needham | Maintains | Buy | $130.00 |
| September 4, 2025 | Evercore ISI Group | Maintains | In-Line | $120.00 |
| September 3, 2025 | Stifel | Maintains | Buy | $100.00 |
| August 29, 2025 | Rosenblatt | Maintains | Neutral | $100.00 |
AI-driven revenue growth sustainability
Ciena's $7.7 billion order backlog and 39.5% year-over-year revenue growth signal strong demand tied to AI infrastructure buildout. With EPS of $1.64 beating estimates of $1.46 and Bank of America issuing a Buy rating with a $660 price target, the company appears well-positioned to capitalize on surging AI network investments.
Despite strong top-line results, Seeking Alpha analysts have flagged unimpressive growth paired with compressing margins, raising concerns about whether AI-driven demand is sustainable or merely cyclical. Morgan Stanley downgraded the stock citing lack of near-term margin upside, suggesting growth may not translate into durable profitability.
Valuation and price target divergence
Raymond James raised its price target to $530 with an Outperform rating, and Bank of America set a $660 target with a Buy, reflecting confidence that Ciena's earnings power justifies a premium valuation. The Moderate Buy consensus and average target of $530.56 support the view that current prices remain reasonable.
UBS maintained a Neutral rating even after raising its target to $508, and Morgan Stanley held an Equal Weight rating with a $490 target. Multiple Seeking Alpha analysts have explicitly stated they see little upside from current levels and have downgraded the stock, questioning whether the valuation already prices in future growth.
Margin trajectory amid heavy infrastructure investment
Ciena outlined a 14% revenue growth target for fiscal 2025 as cloud orders accelerate, and its Q2 earnings beat on both the top and bottom line. Analysts at Raymond James and Bank of America argue that scale benefits and product mix improvements will support margin expansion as AI-related network spending intensifies.
Several Seeking Alpha analysts described Ciena's financials as weak, with compressing margins making it a Hold rather than a Buy. Morgan Stanley's downgrade specifically cited the lack of near-term margin upside, suggesting that rising infrastructure costs and competitive pressures could weigh on profitability even as revenue grows.